Zoetis receives EUA for Simparica Trio
The FDA authorizes the chewable tablets to treat New World screwworm infestations in dogs and puppies during this emergency.
See the latest news and media coverage for Zoetis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global animal health company
zoetis.comLast updated
In short: Zoetis cut 2026 guidance amid pet-care weakness; won FDA approval for Convenia.
The FDA authorizes the chewable tablets to treat New World screwworm infestations in dogs and puppies during this emergency.
Net income was $691 million. The company cites pressured companion animal markets and adjusts full-year organic growth expectations.
Saccaro joins effective August 17, 2026, from GE HealthCare. He leads global finance and operations, while Wetteny Joseph transitions to a special advisor role.
The long-acting anti-NGF monoclonal antibody provides pain relief for up to three months with a single injection
Zoetis (NYSE:ZTS) received FDA approval for Convenia RTU for Dogs, a single-dose antibiotic for...
Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be ...
Zoetis Inc. stock has reached a new 52-week low, hitting a price of $70.97. This marks a significant downturn for the company, which has seen...
In other recent news, Zoetis reported mixed second-quarter 2026 results. The company posted adjusted diluted earnings per share of $1.87, slightly surpassing the forecast of...
Track Zoetis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Zoetis and other trending companies.